According to Reuters, Thorne HealthTech (THRN) a provider of at-home health tests and nutritional supplements, is exploring a sale.

Eliem Therapeutics (ELYM) announces plans to conduct a comprehensive exploration of strategic alternatives focused on maximizing shareholder value.

On July 18, 2023, CSP EAF II GP Limited, as general partner of CSP Fund II LP, an entity affiliated with the CSP Management submitted

According to Reuters, MoonLake Immunotherapeutics (MLTX) a developer of an antibody-derived treatment for inflammatory skin conditions, is exploring a sale.

AG Mortgage Investment Trust, Inc. (MITT) announced that it submitted a proposal to the Board of Directors of Western Asset Mortgage Capital Corporation (WMC) to

AVROBIO (AVRO) announced to halt further development of its programs and to conduct a comprehensive exploration of strategic alternatives focused on maximizing shareholder value.

CalAmp (CAMP) announced the company’s Board of Directors has engaged advisors and formed a special committee to explore all strategic alternatives.

According to Reuters, Cronos Group (CRON), the Canadian cannabis producer backed by cigarette maker Altria Group (MO), is exploring options that include a potential sale

RVL Pharmaceuticals (RVLP), a specialty pharmaceutical company announced that, as authorized by the Board of Directors, the company has been considering certain strategic alternatives including

Histogen (HSTO) announced that it has completed a review of its business, and plans to commence a process to explore strategic alternatives.

PolyMet Mining (PLM) announced that it received a non-binding proposal from Glencore AG to acquire all outstanding shares for cash consideration of $2.11 per share.

Carriage Services (CSV) announced that its Board of Directors has initiated a process to explore potential strategic alternatives, possibly including a sale, merger, or other